Abstract. Macroprolactinemia was recognized more than a decade ago as a cause of hyperprolactinemia and the prevalence of macroprolactinemia is thought to be 10%-26% of patients with hyperprolactinemia. However, there are few published reports about macroprolactinemia in childhood. We report a 7-year-and-1-month-old girl with hyperprolactinemia due to macroprolactinemia with the complication of transient idiopathic central precocious puberty (ICPP). At the age of 6 years and 9 months, she was diagnosed with ICPP at another clinic, on the basis of isolated mammary development and increased height velocity with slightly advanced bone age. At that time, the unexpected finding of high PRL level was also observed. Four months later, she was referred to our clinic for persistently high PRL level. At this time, other endocrinological data showed prepubertal stage and we demonstrated macroprolactinemia and the presence of anti-PRL autoantibody. After other causes of hyperprolactinemia such as prolactinoma and stress were ruled out, we finally diagnosed her with hyperprolactinemia due to macroprolactinemia. Because most patients with macroprolactinemia are symptom-free despite hyperprolactinemia and drug therapy would not be indicated, macroprolactinemia should be suspected even in children to avoid unnecessary examinations and treatments.
HYPERPROLACTINEMIA may be due to pregnancy, stress, pituitary tumors, polycystic ovary syndrome, and primary hypothyroidism. However, some patients with hyperprolactinemia are diagnosed as having idiopathic hyperprolactinemia because the causes are unknown. They are subjected to repeated examinations including radiological examinations to find microadenoma, long-term treatment, and even surgery. On the other hand, macroprolactinemia was recognized more than a decade ago as a cause of hyperprolactinemia in women [1] . Since then, several cases of macroprolactinemia have been reported in adults, particularly in women. However, there are few published reports on macroprolactinemia in childhood. Therefore, we report our experience and hope that pediatricians, as well as gynecologists, can identify this entity and avoid unnecessary studies or treatment.
Case Report
A 7-year-and-1-month old girl was referred to Okayama Medical Center for evaluation because of high serum PRL concentration in January 2006. She had been diagnosed with pervasive developmental disorders and was prescribed dopamine antagonists (ris-peridone) between April 2004 and June 2005 at another clinic. Her family members noticed bilateral breast buds in January 2005 and consulted a doctor at Okayama Rosai Hospital because of remarkable breast enlargement in September 2005 at the age of 6 years and 9 months. At the clinic, physical examination revealed height was 129.8 cm (+2.65 SD) and growth velocity was 7.5 cm/year (+2.29 SD). Her father's height was 180 cm (+1.59 SD) and her mother's height was 165 cm (+1.30 SD), and subsequently her midparental height was 168 cm (+1.87 SD). She had no major anomalies and her proportions were normal. Her breast development was stage 2 and pubic hair was stage 1 by the Tanner stages. Her bone age according to Greulich-Pyle was 8 years (bone age/chronological age = 118.5%). No abnormalities of the chest or abdomen were found.
Her complete blood count, routine serum chemistries and urinalysis were all within normal range. No abnormalities were observed in her hypothalamus, pituitary, ovary or adrenal gland on magnetic resonance imaging (MRI). Taken together, we diagnosed her with idiopathic central precocious puberty and followed her without medication for 4 months.
Because a high serum PRL concentration persisted despite unchanged pubertal stage, she was referred to our hospital to evaluate the high PRL level at the age of 7 years and 1 month.
At our clinic, physical examination revealed that her height was 133.3 cm (+2.57 SD) and growth velocity was 6.8 cm/year (+1.64 SD). Her breast development was stage 3 and pubic hair remained stage 1 by the Tanner stages. Her bone age according to GreulichPyle was 8 years and 10 months (bone age/chronological age = 121.8%). No abnormalities were observed in her hypothalamus or pituitary on MRI, either. The results of endocrinological testing at our clinic are shown in Table 2 . E 2 and basal LH levels were normal, but basal PRL level was still high after standardization for age and sex. GnRH test demonstrated FSH dominance and a slightly incremental rise, indicating prepubertal stage. TRH test demonstrated a blunted PRL response with increased basal concentration as observed at the previous clinic.
Because high PRL level persisted even though other endocrinological data showed prepubertal stage at this time, we suspected macroprolactinemia. We diagnosed her as having macroprolactinemia using the polyethylene glycol (PEG) method, according to the poor recovery (6.25%) of PRL in the supernatant (free PRL) after 12.5% PEG treatment (criteria for macroprolactinemia: recovery less than 40% of the total PRL after 12.5% PEG treatment) [2] . We also demonstrated that 62% of serum PRL was bound to a protein G column, which traps immunoglobulin G (IgG) [3] , suggesting that her macroprolactin was mainly composed of IgG-bound PRL. Taken together, anti-PRL autoantibody was considered to be the contributor to the cause of macroprolactinemia. We also checked her mother for the presence of macroprolactinemia, but she had normal PRL concentrations (8.0 ng/mL) with no macroprolactinemia.
Discussion
Hyperprolactinemia in adults is responsible for oligomenorrhea or amenorrhea, galactorrhea and infertility in women, loss of libido and impotence in men, and in children delayed puberty, galactorreha, gynecomastia, and amenorrhea. The etiology of hyperprolactinemia is diverse and includes drugs, stress, pituitary tumors, polycystic ovary syndrome, and primary hypothyroidism. Drugs include tricyclic antidepressants, phenothiazines, metaclopramide, methyldopa, reserpine and estrogen. Hyperprolactinemia may also be the result of macroprolactin, a complex of monomeric PRL and immunoglobulin G that is thought to have limited biological activity [4] . The prevalence of macroprolactinemia is thought to be 10%-26% of patients with hyperprolactinemia [3, [5] [6] [7] . Most papers have been published in connection with macroprolactinemia in adults, but there are few references available on children. Weill et al. reported the first infant case which was a boy with macroprolactinemia associated with psychosocial dwarfism [8] . In 1997, Fabre-Brue et al. described four girls with macroprolactinemia. Their initial PRL measurement had been performed as part of a routine endocrine investigation for precocious puberty in 2 cases, short stature in 1 case, and nonspecific headaches in 1 case [9] . Fideleff et al. reported 5 asymptomatic cases with macroprolactinemia that was a casual finding. Above all, 2 of their cases were detected during a study they performed on 304 healthy children and adolescents to establish reference values for prolactin [10] . More recently, Tütüncüler et al. presented 6 children with macroprolactinemia, of whom 5 had manifestations consistent with endocrinopathy (headaches, menstrual disturbance, short stature, increased hair and early puberty). In only one patient, macroprolactinemia was found incidentally [11] . As shown above, most cases seemed to be detected during endocrine evaluation, regardless of whether symptoms were attributed to high PRL levels, though some cases were casual findings.
In our case, elevated PRL levels were unexpected and discrepant with the other findings: precocious puberty was observed instead of delayed puberty known to be associated with hyperprolactinemia. At first we thought that elevated estrogen levels induced by precocious puberty was the cause of hyperprolactinemia, but this presumption was easily excluded, because high PRL levels persisted despite normalization of E 2 levels 4 months later. After all, the causal relation between macroprolactinemia and precocious puberty was not made clear and it was thought that both had coexisted by chance as was already reported [9, 11] . Then, we considered risperidone, serotonine-dopamin-antagonist, as a candidate for the cause of hyperprolactinemia, because PRL secretion is primarily under tonic inhibition by dopamine [12] . This presumption was also excluded, because the patient had been off the drug for 1 year. Different causes of hyperprolactinemia and stress were ruled out in view of the PRL values in our patient. Finally, we diagnosed her as having macroprolactinemia.
Anti-PRL autoantibody, which forms large PRLimmunoglobulin complexes that may trap bioactive PRL within capillaries and prevent it from reaching its target cells, is considered to be a leading cause of macroprolactinemia [13] . Consequently, patients with macroprolactinemia are clinically characterized by the lack of hyperprolactinemia-related symptoms in general and show hyperprolactinemia due to delayed clearance of the autoantibody-bound PRL. We demonstrated the presence of the autoantibody in our patient, though such studies were not performed in the children described before. Macroprolactinemia has occasionally been shown to occur in several members of the same family [14] and the observation by Jackson et al. was in keeping with the hypothesis of maternally transmitted antibodies [15] . Fabre-Brue et al. [9] and Fideleff et al. [10] checked the brothers of their patients for the presence of hyperprolactinemia, but they had normal PRL concentrations. We also checked the mother of our patient, but she had normal PRL level with no macroprolactinemia. Thus, the underlying cause of macroprolactinemia is of diverse etiology.
Once the diagnosis of macroprolactinemia has been confirmed, drug therapy is not indicated, but dopaminergic treatment may sometimes be beneficial [6, 11] . Most patients reported that the presence with macroprolactinemia lacks clinical manifestations typical of hyperprolactinemic syndrome, but some of the usual symptoms of hyperprolactinemia are present [6] . So, patients should be followed for clinical symptoms.
In conclusion, macroprolactinemia should be suspected in children as well as adult females, especially when asymptomatic or associated with non-specific clinical features or even associated with relevant symptoms of increased PRL levels. Early diagnosis will avoid unnecessary studies, including repeated imaging studies, which is particularly important in children.
